{
    "Trade/Device Name(s)": [
        "CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel",
        "Influenza A/B Typing Kit"
    ],
    "Submitter Information": "Centers for Disease Control and Prevention",
    "510(k) Number": "K133869",
    "Predicate Device Reference 510(k) Number(s)": [
        "K132508"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OZE",
        "NSU",
        "NXD"
    ],
    "Summary Letter Date": "January 17, 2014",
    "Summary Letter Received Date": "December 20, 2013",
    "Submission Date": "December 19, 2013",
    "Regulation Number(s)": [
        "21 CFR 866.3980"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Influenza A virus",
        "Influenza B virus"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab",
        "Nasal swab",
        "Throat swab",
        "Nasal aspirate",
        "Nasal wash",
        "Dual nasopharyngeal/throat swab",
        "Bronchoalveolar lavage",
        "Bronchial wash",
        "Tracheal aspirate",
        "Sputum",
        "Lung tissue",
        "Viral culture"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Applied Biosystems 7500 Fast Dx Real-Time PCR Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time RT-PCR"
    ],
    "Methodologies": [
        "RT-PCR",
        "Molecular detection"
    ],
    "Submission Type(s)": [
        "Kit",
        "Reagent",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel, Influenza A/B Typing Kit for detection and surveillance of influenza A/B viruses in respiratory specimens using RT-PCR technology.",
    "Indications for Use Summary": "Qualitative detection of influenza virus type A or B from viral RNA in upper and lower respiratory tract specimens and viral culture from human patients with signs and symptoms of respiratory infection; provides epidemiologic information for surveillance of circulating influenza viruses.",
    "fda_folder": "Microbiology"
}